November 22, 2018
Oasmia’s Apalea approved in Europe for ovarian cancer
After the Oasmia Pharmaceutical’s pivotal study OAS 07OVA conducted on ovarian cancer patients with disease relapse, showed that the risks…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: EC
September 28, 2017
European Comission OKs Sanogi’s, Regeneron’s dermatitis treatment Dupixent
Sanofi and Regeneron Pharmaceuticals got European Commission marketing authorization for Dupixent for use in adults with moderate-to-severe atopic dermatitis (AD)…
July 22, 2017
The first targeted treatment for newly diagnosed certain Leukemia in the EU
Novartis on Friday said that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion recommending approval of Rydapt (midostaurin) for the treatment of adults with newly diagnosed acute myeloid leukemia (AML) who are FLT3 mutation-positive.
June 1, 2017
BioMarin cleared in EU for TPP1 deficiency treatment
BioMarin Pharmaceuticalsaid today that it got from the European Commission (EC) a grant for Brineura (cerliponase alfa), the first treatment approved in the European Union (EU) for tripeptidyl peptidase 1 (TPP1) deficiency.